hipralona enro i 50.00 mg/ml
laboratorios hipra, s.a. - Энрофлоксацин - инжекционен разтвор - 50.00 mg/ml - свине, телета
hipradoxi s 100.00 mg/ml
laboratorios hipra, s.a. - Доксициклин (гиклат) - перорален разтвор - 100.00 mg/ml - пилета, прасета
dasatinib accordpharma
accord healthcare s.l.u. - дазатиниб - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - Антинеопластични средства - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
imatinib glenmark loomg film - coated tablet
glenmark pharmaceuticals s.r.o., - loomg film - coated tablet
imatinib glenmark 400mg film - coated tablet
glenmark pharmaceuticals s.r.o., - 400mg film - coated tablet
beyfortus
astrazeneca ab - nirsevimab - Имунни серуми и имуноглобулини - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season. beyfortus should be used in accordance with official recommendations.
breyanzi
bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - Антинеопластични средства - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.
hipragumboro gm97
laboratorios hipra, s.a. - Вирус е инфекциозно бурсальной болест (ibdv), щам gm97 - лиофилизат за перорална суспензия - 10 на 2 степен - 10 на 3 степен eid50 - бройлери
hipraviar trt4
laboratorios hipra, s.a. - Вирус на нюкасълска болест (НДВ), щам Ла "пчелна пита"; вирус на инфекциозен бронхит (ibv), прецедете h52; вирус на болестта Гамборо, щам w2512; вируса на Турция rhinotrachetis, щам 1062 - инжекционна емулсия - ≥ 819 hau; ≥ 10 на 6 степен eid 50; ≥ 10 на 5.5 степен eid 50; ≥ 10 на 6 степен dict 50 - птици
ciprofloxacin hikma 200 mg/100 ml solution for infusion
hikma farmaceutica (portugal), s.a. - ciprofloxacin - 200 mg/100 ml solution for infusion